- Home
- STRO vs GGT Comparison
STRO vs GGT Comparison
Compare STRO & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- GGT
- Stock Information
- Founded
- STRO 2003
- GGT 1994
- Country
- STRO United States
- GGT United States
- Employees
- STRO N/A
- GGT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- GGT Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- GGT Finance
- Exchange
- STRO Nasdaq
- GGT Nasdaq
- Market Cap
- STRO 147.6M
- GGT 136.0M
- IPO Year
- STRO 2018
- GGT N/A
- Fundamental
- Price
- STRO $1.77
- GGT $4.79
- Analyst Decision
- STRO Strong Buy
- GGT
- Analyst Count
- STRO 7
- GGT 0
- Target Price
- STRO $12.14
- GGT N/A
- AVG Volume (30 Days)
- STRO 950.7K
- GGT 59.7K
- Earning Date
- STRO 03-24-2025
- GGT 01-01-0001
- Dividend Yield
- STRO N/A
- GGT 15.56%
- EPS Growth
- STRO N/A
- GGT N/A
- EPS
- STRO N/A
- GGT 0.83
- Revenue
- STRO $160,955,000.00
- GGT N/A
- Revenue This Year
- STRO N/A
- GGT N/A
- Revenue Next Year
- STRO N/A
- GGT N/A
- P/E Ratio
- STRO N/A
- GGT $6.90
- Revenue Growth
- STRO 230.90
- GGT N/A
- 52 Week Low
- STRO $1.51
- GGT $4.32
- 52 Week High
- STRO $6.13
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- GGT 47.91
- Support Level
- STRO $1.76
- GGT $4.78
- Resistance Level
- STRO $1.95
- GGT $4.87
- Average True Range (ATR)
- STRO 0.13
- GGT 0.05
- MACD
- STRO 0.00
- GGT -0.01
- Stochastic Oscillator
- STRO 41.94
- GGT 21.05
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.